Issuer · CIK 0002042347
SPTX — Seaport Therapeutics, Inc.
Recent filings
- May 4, 2026·Form 4·Other—
SPTX/Seaport Therapeutics, Inc.
Zohar Daphne · Chief Executive Officer
scoring - May 4, 2026·Form 4·Other—
SPTX/Seaport Therapeutics, Inc.
HEALY JAMES · director
scoring - May 4, 2026·Form 4·Other—
SPTX/Seaport Therapeutics, Inc.
White Lauren · Chief Financial Officer
scoring - May 4, 2026·Form 4·Other—
SPTX/Seaport Therapeutics, Inc.
Wheadon David E. · director
scoring - May 4, 2026·Form 4·Other—
SPTX/Seaport Therapeutics, Inc.
PETERSON SANDRA E · director
scoring - May 4, 2026·Form 4·Other—
SPTX/Seaport Therapeutics, Inc.
Gladstein Lana · General Counsel
scoring - May 4, 2026·Form 4·Other—
SPTX/Seaport Therapeutics, Inc.
Chen Michael Cunyuan · Chief Scientific Officer
scoring - May 4, 2026·Form 4·Other—
SPTX/Seaport Therapeutics, Inc.
Torres Denice · director
scoring - May 4, 2026·Form 4·Other—
SPTX/Seaport Therapeutics, Inc.
PAUL STEVEN M · director
scoring - May 4, 2026·Form 4·Buy$19.8M
SPTX/Seaport Therapeutics, Inc.
ARCH Venture Partners XII, LLC · 10pct_owner
32conviction - May 4, 2026·Form 4·Other—
SPTX/Seaport Therapeutics, Inc.
HOMBACH ROBERT J. · director
scoring - May 4, 2026·Form 4·Other—
SPTX/Seaport Therapeutics, Inc.
Loebel Antony · Chief Medical Officer
scoring - May 4, 2026·Form 4·Other—
SPTX/Seaport Therapeutics, Inc.
Mates Sharon · director
scoring